您的位置: 首页 > 农业专利 > 详情页

N-terminal modified PEG-TRAIL, method of manufacture and uses thereof
专利权人:
Theraly Pharmaceuticals Inc.
发明人:
LEE, Kang Choon,LEE, Sung Kwon,CHAE, Su Young,YOUN, Yu Seok,KIM, Won Bae
申请号:
DK07746877
公开号:
DK2026842T3
申请日:
2007.06.12
申请国别(地区):
DK
年份:
2017
代理人:
摘要:
Disclosed herein are an N-terminal modified PEG-TRAIL conjugate and a preparation method and use thereof. The PEG-TAIL conjugate has pharmaceutical activity identical or similar to that of native TRAIL (TNF-related apoptosis-inducing ligand) with extended in vivo half-life and enhanced stability. Compared to native TRAIL, the PEG-TAIL conjugate exhibits high solubility and solution stability, with highly improved pharmacokinetic profiles. Thus, the PEG-TAIL conjugate may be very useful for preventing and treating proliferative diseases and autoimmune diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充